Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Idebenone in MELAS
NCT00887562Phase 2Completed
- Start
- May 2009
- Primary completion
- Jul 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of idebenone in mitochondrial encephalomyopathy lactic acidosis and stroke-like episodes (MELAS) (3 arms). Primary endpoint: Mean Change in Cerebral Lactate Concentration (as Measured by Magnetic Resonance Spectroscopy) at 4 weeks. Started May 2009; status: completed.
02
Drugs
idebenone
03
Conditions
mitochondrial encephalomyopathy lactic acidosis and stroke-like episodes (MELAS)
Beyond the preview
Go deeper on NCT00887562.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00887562.